Total Payments
$5,397
2024 Payments
$28.62
Companies
9
Transactions
656
Payment Breakdown by Category
Food & Beverage$3,722 (69.0%)
Consulting$1,591 (29.5%)
Education$83.81 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,722 | 644 | 69.0% |
| Consulting Fee | $1,591 | 1 | 29.5% |
| Education | $83.81 | 11 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $3,136 | 217 | $0 (2019) |
| Lundbeck LLC | $785.45 | 210 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $373.81 | 79 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $263.80 | 42 | $0 (2019) |
| Allergan Inc. | $261.28 | 28 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $205.12 | 48 | $0 (2018) |
| Vanda Pharmaceuticals Inc. | $159.24 | 18 | $0 (2019) |
| ABBVIE INC. | $115.30 | 7 | $0 (2024) |
| Alkermes, Inc. | $96.96 | 7 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $28.62 | 2 | ABBVIE INC. ($28.62) |
| 2022 | $55.66 | 3 | ABBVIE INC. ($55.66) |
| 2021 | $31.02 | 2 | AbbVie Inc. ($31.02) |
| 2019 | $941.99 | 140 | Otsuka America Pharmaceutical, Inc. ($434.62) |
| 2018 | $3,245 | 265 | Otsuka America Pharmaceutical, Inc. ($2,234) |
| 2017 | $1,095 | 244 | Otsuka America Pharmaceutical, Inc. ($467.61) |
All Payment Transactions
656 individual payment records from CMS Open Payments — Page 1 of 27
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.23 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.91 | General |
| Category: NEUROSCIENCE | ||||||
| 05/03/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.87 | General |
| Category: NEUROSCIENCE | ||||||
| 03/24/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/28/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.39 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2021 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2019 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug) | Food and Beverage | In-kind items and services | $8.53 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $3.00 | General |
| Category: Central Nervous System | ||||||
| 10/02/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $2.42 | General |
| Category: PSYCHIATRY | ||||||
| 10/02/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.38 | General |
| Category: Central Nervous System | ||||||
| 10/01/2019 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $2.90 | General |
| Category: PSYCHIATRY | ||||||
| 10/01/2019 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $1.62 | General |
| Category: PSYCHIATRY | ||||||
| 09/30/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $8.99 | General |
| Category: Central Nervous System | ||||||
| 09/25/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $3.75 | General |
| Category: PSYCHIATRY | ||||||
| 09/25/2019 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $1.96 | General |
| Category: Central Nervous System | ||||||
| 09/23/2019 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $3.50 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2019 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $7.35 | General |
| Category: PSYCHIATRY | ||||||
| 09/19/2019 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $3.49 | General |
| Category: PSYCHIATRY | ||||||
| 09/17/2019 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $7.79 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $4.89 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2019 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $4.33 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2019 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $5.25 | General |
| Category: PSYCHIATRY | ||||||
| 09/04/2019 | Lundbeck LLC | ABILIFY MAINTENA (Drug) | Food and Beverage | Cash or cash equivalent | $5.22 | General |
| Category: PSYCHIATRY | ||||||
About Dr. Sarah Hardy, D.O
Dr. Sarah Hardy, D.O is a Psychiatry healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1487833067.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sarah Hardy, D.O has received a total of $5,397 in payments from pharmaceutical and medical device companies, with $28.62 received in 2024. These payments were reported across 656 transactions from 9 companies. The most common payment nature is "Food and Beverage" ($3,722).
Ad
Practice Information
- Specialty Psychiatry
- Other Specialties Psychiatry
- Location Fort Worth, TX
- Active Since 10/30/2007
- Last Updated 05/31/2023
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1487833067
Products in Payments
- BREXPIPRAZOLE (Drug) $1,591
- REXULTI (Drug) $1,219
- ABILIFY MAINTENA (Drug) $1,111
- VRAYLAR (Drug) $364.09
- AUSTEDO (Drug) $263.80
- LATUDA (Drug) $205.12
- INVEGA TRINZA (Drug) $190.52
- Fanapt (Drug) $159.24
- INVEGA SUSTENNA (Drug) $93.07
- Aristada 441 mg (Drug) $84.53
- LINZESS (Drug) $12.49
- ARISTADA (Drug) $12.43
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Fort Worth
Dr. Andrew Kim, M.d, M.D
Psychiatry — Payments: $338,400
Psychiatry $338,400
Garrick Prejean, M.d, M.D
Psychiatry — Payments: $9,721
Psychiatry $9,721
Patricia Lowrimore, M.d, M.D
Psychiatry — Payments: $9,219
Psychiatry $9,219
Geetha Reddy, M.d, M.D
Psychiatry — Payments: $8,510
Psychiatry $8,510
Dr. Keisha Yahagi, M.d, M.D
Psychiatry — Payments: $7,802
Psychiatry $7,802
Dr. Kishore Sunkara, M.d, M.D
Psychiatry — Payments: $6,515
Psychiatry $6,515